BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Cerci JJ, Bogoni M, Buccheri V, Etchebehere ECSC, Silveira TMBD, Baiocchi O, Neto CACP, Sapienza MT, Marin JFG, Meneghetti JC, Novis Y, Souza CA, Chiattone C, Torresan M, Ramos CD. Fluorodeoxyglucose-positron emission tomography staging can replace bone marrow biopsy in Hodgkin's lymphoma. Results from Brazilian Hodgkin's Lymphoma Study Group. Hematol Transfus Cell Ther 2018;40:245-9. [PMID: 30128433 DOI: 10.1016/j.htct.2018.03.002] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
Number Citing Articles
1 Gebreslassie KS, Bassa FC, Chapanduka ZC, Warwick JM. The relationship between bone marrow involvement on 18F-FDG PET/CT and bone marrow biopsy in patients with multiple myeloma and other plasma cell neoplasms. S Afr j oncol 2022;6. [DOI: 10.4102/sajo.v6i0.197] [Reference Citation Analysis]
2 Büyükşimşek M, Kolsuz İ, Yetişir AE, Tohumcuoğlu M, Oğul A, Mirili C, Paydaş S, Güney İB. Performance of Positron Emission Tomography-Computed Tomography and Bone Marrow Biopsy in Detecting Bone Marrow Infiltration in Lymphoma Cases. Turk J Haematol 2020;37:220-5. [PMID: 32003552 DOI: 10.4274/tjh.galenos.2020.2019.0361] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]